NEMO reshapes the α-Synuclein aggregate interface and acts as an autophagy adapter by co-condensation with p62
Nikolas Furthmann,Verian Bader,Lena Angersbach,Alina Blusch,Simran Goel,Ana Sánchez-Vicente,Laura J Krause,Sarah A Chaban,Prerna Grover,Victoria A Trinkaus,Eva M van Well,Maximilian Jaugstetter,Kristina Tschulik,Rune Busk Damgaard,Carsten Saft,Gisa Ellrichmann,Ralf Gold,Arend Koch,Benjamin Englert,Ana Westenberger,Christine Klein,Lisa Jungbluth,Carsten Sachse,Christian Behrends,Markus Glatzel,F Ulrich Hartl,Ken Nakamura,Chadwick W Christine,Eric J Huang,Jörg Tatzelt,Konstanze F Winklhofer
DOI: https://doi.org/10.1038/s41467-023-44033-0
2023-12-19
Abstract:NEMO is a ubiquitin-binding protein which regulates canonical NF-κB pathway activation in innate immune signaling, cell death regulation and host-pathogen interactions. Here we identify an NF-κB-independent function of NEMO in proteostasis regulation by promoting autophagosomal clearance of protein aggregates. NEMO-deficient cells accumulate misfolded proteins upon proteotoxic stress and are vulnerable to proteostasis challenges. Moreover, a patient with a mutation in the NEMO-encoding IKBKG gene resulting in defective binding of NEMO to linear ubiquitin chains, developed a widespread mixed brain proteinopathy, including α-synuclein, tau and TDP-43 pathology. NEMO amplifies linear ubiquitylation at α-synuclein aggregates and promotes the local concentration of p62 into foci. In vitro, NEMO lowers the threshold concentrations required for ubiquitin-dependent phase transition of p62. In summary, NEMO reshapes the aggregate surface for efficient autophagosomal clearance by providing a mobile phase at the aggregate interphase favoring co-condensation with p62.